By Charles Grob — 1996
On November 26, 1996, Charles Grob, M.D. visited with Albert Hofmann in Rheinfelden, outside of Basel, Switzerland, where Dr. Hofmann was recovering from knee surgery. The following are excerpts from their conversation.
Read on maps.org
CLEAR ALL
The drug lowers brain barriers, allowing distant regions to talk and thoughts to flow more freely.
The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.
1
In the world’s largest study on psychedelics and the brain, a team of researchers from The Neuro (Montreal Neurological Institute-Hospital) and Department of Biomedical Engineering of McGill University, the Broad Institute at Harvard/MIT, SUNY Downstate Health Sciences University, and Mila—Quebec...
Psychedelic drugs like psilocybin are being tested to treat mental illness. They're also expanding our understanding about human consciousness.
Scientists are looking into what psychedelics do to inspire people to act pro-environmentally.
To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.
It seems that psychedelics do more than simply alter perception. According to the latest research from my colleagues and me, they change the structures of neurons themselves.
Science is finally catching up with the potential powers of this psychedelic drink.
A new brain-scan study helps explain how psilocybin works—and why it holds promise as a treatment for depression, addiction and post-traumatic stress.
How magic mushrooms expand consciousness.
2